HCV RNA positivity among hepatitis C patients in Chongqing, China from 2004 to 2021: a cross-sectional study

Abstract Background A substantial number of hepatitis C virus (HCV) infections have been diagnosed and reported, yet not all reported patients have received treatment, leading to uncertainties in the progression of the virus within these cases. This study aimed to assess the rate of HCV RNA positivi...

Full description

Saved in:
Bibliographic Details
Main Authors: Yaping He, Shaodong Ye, Wei Zhang, Rongrong Lu, Jing Lin, Chao Zhou, Guohui Wu
Format: Article
Language:English
Published: BMC 2024-11-01
Series:BMC Infectious Diseases
Subjects:
Online Access:https://doi.org/10.1186/s12879-024-09978-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850244256367640576
author Yaping He
Shaodong Ye
Wei Zhang
Rongrong Lu
Jing Lin
Chao Zhou
Guohui Wu
author_facet Yaping He
Shaodong Ye
Wei Zhang
Rongrong Lu
Jing Lin
Chao Zhou
Guohui Wu
author_sort Yaping He
collection DOAJ
description Abstract Background A substantial number of hepatitis C virus (HCV) infections have been diagnosed and reported, yet not all reported patients have received treatment, leading to uncertainties in the progression of the virus within these cases. This study aimed to assess the rate of HCV RNA positivity in the reported cases in Chongqing, China and identify key groups. Methods An investigation was conducted on 6,333 hepatitis C cases who were reported in the China Information System for Disease Control and Prevention in 17 districts of Chongqing, China from 2004 to 2021. The process involved collecting venous blood for HCV RNA and genotype testing, as well as gathering case information through a questionnaire. The analysis focused on comparing the HCV RNA positive rates among patients with different characteristics to identify key groups. Results The HCV RNA positive rate was 37.7% among 6,333 cases. Patients who had never received treatment (47.6%) and those treated with interferon (25.6%) showed higher positive rates than those treated with DAAs (8.1%). HCV RNA positive rates were generally higher in the following groups: males, aged 40–49 years and 50–59 years, farmers or manual laborers and the unemployed or job-seeking. Patients with higher income exhibited lower HCV RNA positive rate. Conclusions A considerable portion of reported hepatitis C cases in Chongqing remained HCV RNA positive. Multiple factors contributed to HCV RNA positivity among these patients, necessitating comprehensive interventions to promote adherence to treatment.
format Article
id doaj-art-9ee0be648aa34f038f17f03daa223ce5
institution OA Journals
issn 1471-2334
language English
publishDate 2024-11-01
publisher BMC
record_format Article
series BMC Infectious Diseases
spelling doaj-art-9ee0be648aa34f038f17f03daa223ce52025-08-20T01:59:48ZengBMCBMC Infectious Diseases1471-23342024-11-012411710.1186/s12879-024-09978-7HCV RNA positivity among hepatitis C patients in Chongqing, China from 2004 to 2021: a cross-sectional studyYaping He0Shaodong Ye1Wei Zhang2Rongrong Lu3Jing Lin4Chao Zhou5Guohui Wu6Chongqing Municipal Center for Disease Control and PreventionNational Center for AIDS and STD Control and Prevention, Chinese Center for Disease Control and PreventionChongqing Municipal Center for Disease Control and PreventionChongqing Municipal Center for Disease Control and PreventionChongqing Municipal Center for Disease Control and PreventionChongqing Municipal Center for Disease Control and PreventionChongqing Municipal Center for Disease Control and PreventionAbstract Background A substantial number of hepatitis C virus (HCV) infections have been diagnosed and reported, yet not all reported patients have received treatment, leading to uncertainties in the progression of the virus within these cases. This study aimed to assess the rate of HCV RNA positivity in the reported cases in Chongqing, China and identify key groups. Methods An investigation was conducted on 6,333 hepatitis C cases who were reported in the China Information System for Disease Control and Prevention in 17 districts of Chongqing, China from 2004 to 2021. The process involved collecting venous blood for HCV RNA and genotype testing, as well as gathering case information through a questionnaire. The analysis focused on comparing the HCV RNA positive rates among patients with different characteristics to identify key groups. Results The HCV RNA positive rate was 37.7% among 6,333 cases. Patients who had never received treatment (47.6%) and those treated with interferon (25.6%) showed higher positive rates than those treated with DAAs (8.1%). HCV RNA positive rates were generally higher in the following groups: males, aged 40–49 years and 50–59 years, farmers or manual laborers and the unemployed or job-seeking. Patients with higher income exhibited lower HCV RNA positive rate. Conclusions A considerable portion of reported hepatitis C cases in Chongqing remained HCV RNA positive. Multiple factors contributed to HCV RNA positivity among these patients, necessitating comprehensive interventions to promote adherence to treatment.https://doi.org/10.1186/s12879-024-09978-7Hepatitis C virusHCV RNAHCV genotypeEpidemiology
spellingShingle Yaping He
Shaodong Ye
Wei Zhang
Rongrong Lu
Jing Lin
Chao Zhou
Guohui Wu
HCV RNA positivity among hepatitis C patients in Chongqing, China from 2004 to 2021: a cross-sectional study
BMC Infectious Diseases
Hepatitis C virus
HCV RNA
HCV genotype
Epidemiology
title HCV RNA positivity among hepatitis C patients in Chongqing, China from 2004 to 2021: a cross-sectional study
title_full HCV RNA positivity among hepatitis C patients in Chongqing, China from 2004 to 2021: a cross-sectional study
title_fullStr HCV RNA positivity among hepatitis C patients in Chongqing, China from 2004 to 2021: a cross-sectional study
title_full_unstemmed HCV RNA positivity among hepatitis C patients in Chongqing, China from 2004 to 2021: a cross-sectional study
title_short HCV RNA positivity among hepatitis C patients in Chongqing, China from 2004 to 2021: a cross-sectional study
title_sort hcv rna positivity among hepatitis c patients in chongqing china from 2004 to 2021 a cross sectional study
topic Hepatitis C virus
HCV RNA
HCV genotype
Epidemiology
url https://doi.org/10.1186/s12879-024-09978-7
work_keys_str_mv AT yapinghe hcvrnapositivityamonghepatitiscpatientsinchongqingchinafrom2004to2021acrosssectionalstudy
AT shaodongye hcvrnapositivityamonghepatitiscpatientsinchongqingchinafrom2004to2021acrosssectionalstudy
AT weizhang hcvrnapositivityamonghepatitiscpatientsinchongqingchinafrom2004to2021acrosssectionalstudy
AT rongronglu hcvrnapositivityamonghepatitiscpatientsinchongqingchinafrom2004to2021acrosssectionalstudy
AT jinglin hcvrnapositivityamonghepatitiscpatientsinchongqingchinafrom2004to2021acrosssectionalstudy
AT chaozhou hcvrnapositivityamonghepatitiscpatientsinchongqingchinafrom2004to2021acrosssectionalstudy
AT guohuiwu hcvrnapositivityamonghepatitiscpatientsinchongqingchinafrom2004to2021acrosssectionalstudy